Homo sapiens (human)

Summary
Taxonomy ID
9606
PubChem Taxonomy
9606
Displaying entries 12626 - 12650 of 18496 in total
UniProt ID Protein Name Gene Symbol No. of Glycosylation Sites No. of GlyTouCan IDs ▼ Disease Ontology
F5H1T4 receptor protein-tyrosine kinase
  • ERBB2
2 0
A0A0K0Q0G7 Rhodopsin
  • RHO
2 0
F5H4C6 Glucosamine (N-acetyl)-6-sulfatase (Fragment)
  • GNS
5 0
Q9BZG2 Testicular acid phosphatase
  • ACP4
  • ACPT
4 0
A0A2I6Q794 MHC class I antigen
  • HLA-B
1 0
A0A2I6PN80 MHC class I antigen
  • HLA-B
1 0
F5H1E8 Alpha-2-macroglobulin
  • A2M
2 0
A0A1B0GU74 Voltage-dependent P/Q-type calcium channel subunit alpha
  • CACNA1A
1 0
C9WCV6 MHC class I antigen (Fragment)
  • HLA-B
1 0
A0A6Q8PFA9 Alpha-galactosidase
  • GLA
2 0
Q05D91 Hypoxia up-regulated protein 1 (Fragment)
  • HYOU1
2 0
Q8N6L6 C3/C5 convertase
  • C2
1 0
C9WCR1 MHC class I antigen (Fragment)
  • HLA-B
1 0
A0A0N7A4C9 MHC class I antigen (Fragment)
  • HLA-B
1 0
G1EPU3 MHC class I antigen (Fragment)
  • HLA-B
1 0
A0A7P0TBJ5 Voltage-dependent L-type calcium channel subunit alpha
  • CACNA1S
2 0
A0A0G3EHL4 MHC class I antigen (Fragment)
  • HLA-C
1 0
A0A7L4X6S8 MHC class I antigen
  • HLA-B
1 0
O75795 UDP-glucuronosyltransferase 2B17
  • UGT2B17
3 0
A0A1Z2RTS6 MHC class I antigen
  • HLA-C
1 0
A0A7I2V5Q0 ADAM metallopeptidase domain 9
  • ADAM9
3 0
A0A0S4T1H1 MHC class I antigen
  • HLA-C
1 0
O00292 Left-right determination factor 2
  • LEFTY2
  • EBAF
  • LEFTA
  • LEFTYA
  • TGFB4
1 0
R5A8Z1 MHC class I antigen (Fragment)
  • HLA-B
1 0
H3BUX1 Mesothelin (Fragment)
  • MSLN
3 0

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024